Lexaria Bioscience Corp. (LEXX)
1.03
+0.04
(+4.57%)
USD |
NASDAQ |
Apr 17, 16:00
1.03
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow : -9.470M for Feb. 28, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -19.96M |
| Aurinia Pharmaceuticals, Inc. | 135.69M |
| Edesa Biotech, Inc. | -8.004M |
| Xenon Pharmaceuticals, Inc. | -280.51M |
| ProMIS Neurosciences, Inc. | -28.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.164M |
| Cash from Investing (Quarterly) | -0.0539M |
| Cash from Financing (Quarterly) | 3.044M |
| Free Cash Flow Per Share (Quarterly) | -0.0908 |
| Free Cash Flow to Equity (Quarterly) | -2.212M |
| Free Cash Flow to Firm (Quarterly) | -2.220M |
| Free Cash Flow Yield | -43.95% |